Wellage Post Procedure
FDA Label NDC 69346-1001

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Hugel Pharma Co.,ltd. for the product Wellage Post Procedure (NDC 69346-1001). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding otc - active ingredient, inactive ingredient, otc - purpose, otc - keep out of reach of children, indications & usage, warnings, dosage & administration, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

Otc - Active Ingredient

glycerin


Inactive Ingredient

water, cyclopentasiloxane, zinc oxide, titanium dioxide, arbutin, dimethicone, talc, sodium chloride, etc


Otc - Purpose

anti wrinkle
whitening
sun block


Otc - Keep Out Of Reach Of Children

keep out or reach of the children


Indications & Usage

ake a proper amount and apply on the face evenly

Warnings

Do not use in the following cases(Eczema and scalp wounds)
Due to the use of this druf if rash, irritation, itching and symptopms of hypersnesitivity occur dicontinue use and consult ypur phamacisr or doctor
If in contact with the eyes, wash out thoroughty with water If the symptoms are servere, seek medical advice immediately
This product is for exeternal use only. Do not use for internal use
Storage and handling precautions
If possible, avoid direct sunlight and store in cool and area of low humidity
In order to maintain the quality of the product and avoid misuse
Avoid placing the product near fire and store out in reach of children


Dosage & Administration

for external use only


* Please review the disclaimer below.